Target type: biologicalprocess
Any process that activates or increases the duration or quality of non-rapid eye movement (NREM) sleep. [GOC:go_curators]
The positive regulation of the circadian sleep/wake cycle, specifically non-REM sleep, is a complex biological process involving a coordinated interplay of various molecular mechanisms. It entails the enhancement or activation of cellular processes that promote the transition into and maintenance of non-REM sleep, aligning with the body's internal biological clock. This regulation encompasses a multitude of factors, including:
- **Circadian Rhythms:** The central circadian pacemaker, located in the suprachiasmatic nucleus (SCN) of the hypothalamus, generates a roughly 24-hour rhythm that influences sleep-wake cycles. The SCN receives light cues from the environment, synchronizing its output with the external day-night cycle. This rhythmic activity is transmitted to various peripheral oscillators throughout the body, influencing diverse physiological processes, including sleep regulation.
- **Neurotransmitter Signaling:** Neurotransmitters play a crucial role in the modulation of sleep. Key players include:
- **Melatonin:** Synthesized by the pineal gland, melatonin levels increase in the evening, promoting sleep onset and duration.
- **GABA:** A major inhibitory neurotransmitter in the brain, GABA promotes relaxation and sleepiness by reducing neuronal activity.
- **Serotonin:** Although known for its mood-regulating properties, serotonin also plays a role in sleep-wake regulation.
- **Histamine:** While histamine is associated with wakefulness, its suppression contributes to sleep initiation.
- **Hormonal Influences:** Hormones contribute to sleep regulation, with notable examples being:
- **Cortisol:** A stress hormone, cortisol levels typically peak in the morning, promoting wakefulness, and decline in the evening.
- **Growth Hormone:** Released during sleep, growth hormone plays a crucial role in tissue repair and development.
- **Sleep-Promoting Factors:** Specific sleep-promoting factors contribute to the initiation and maintenance of non-REM sleep, including:
- **Adenosine:** As neurons become active, adenosine accumulates in the brain, promoting sleepiness.
- **Prostaglandins:** These lipid molecules influence sleep regulation, with some promoting sleepiness.
- **Molecular Mechanisms:** At the molecular level, various signaling pathways and gene expression changes underlie the regulation of non-REM sleep. This includes the involvement of:
- **CLOCK and BMAL1:** These transcription factors drive the circadian clock, regulating the expression of other genes involved in sleep regulation.
- **PER and CRY:** These proteins feedback on CLOCK and BMAL1, modulating their activity and thus influencing circadian rhythms.
- **Homeostatic Regulation:** Sleep drive, reflecting the accumulated need for sleep, influences the duration and intensity of non-REM sleep. This drive is influenced by factors such as sleep deprivation and wakefulness duration.
Overall, the positive regulation of the circadian sleep/wake cycle, non-REM sleep, involves a complex interplay of neural, hormonal, and molecular mechanisms. This intricate system ensures that sleep occurs in a rhythmic manner, synchronized with the external environment, contributing to overall health and well-being.'
"
Protein | Definition | Taxonomy |
---|---|---|
Melatonin receptor type 1B | A melatonin receptor type 1B that is encoded in the genome of human. [PRO:WCB, UniProtKB:P49286] | Homo sapiens (human) |
Compound | Definition | Classes | Roles |
---|---|---|---|
melatonin | acetamides; tryptamines | anticonvulsant; central nervous system depressant; geroprotector; hormone; human metabolite; immunological adjuvant; mouse metabolite; radical scavenger | |
methylbufotenin | 5-methoxy-N,N-dimethyltryptamine : A tryptamine alkaloid that is N,N-dimethyltryptamine substituted by a methoxy group at position 5. | aromatic ether; tertiary amino compound; tryptamine alkaloid | hallucinogen; plant metabolite |
6-chloromelatonin | acetamides | ||
6-hydroxymelatonin | 6-hydroxymelatonin : A member of the class of tryptamines that is melatonin with a hydroxy group substituent at position 6. | acetamides; tryptamines | metabolite; mouse metabolite |
catechin | (+)-catechin : The (+)-enantiomer of catechin and a polyphenolic antioxidant plant metabolite. catechin : Members of the class of hydroxyflavan that have a flavan-3-ol skeleton and its substituted derivatives. Catechin: An antioxidant flavonoid, occurring especially in woody plants as both (+)-catechin and (-)-epicatechin (cis) forms. rac-catechin : A racemate comprising equimolar amounts of (+)- and (-)-catechin | catechin | antioxidant; plant metabolite |
4,4'-bisphenol f | 4,4'-bisphenol F: RN given refers to parent cpd bisphenol F : A bisphenol that is methane in which two of the hydrogens have been replaced by 4-hydroxyphenyl groups. | bisphenol; diarylmethane | environmental food contaminant; xenoestrogen |
s20098 | acetamides | ||
6-methoxy-2,3,4,9-tetrahydropyrido[3,4-b]indol-1-one | beta-carbolines | ||
2-iodomelatonin | acetamides | ||
luzindole | luzindole : A member of the class of indoles that is tryptamine in which one of the amino hydrogens is replaced by an acetyl group while the hydrogen at position 2 is replaced by a benzyl group. luzindole: melatonin receptor antagonist; structure given in first source | acetamides; indoles | melatonin receptor antagonist |
2-bromomelatonin | 2-bromomelatonin: structure given in first source | ||
5-methoxyluzindole | |||
ramelteon | ramelteon: melatonin MT1/MT2 receptor agonist | indanes | |
ah 001 | AH 001: structure given in first source; a melatonin agonist | ||
4-phenyl-2-propionamidotetraline | 4-phenyl-2-propionamidotetraline: melatonin receptor antagonist; structure in first source | tetralins | |
2-phenylmelatonin | phenylindole | ||
iik7 | IIK7: structure in first source | ||
5-methoxycarbonylamino-n-acetyltryptamine | 5-methoxycarbonylamino-N-acetyltryptamine: an mt1/MT2 receptor agonist | acetamides | |
8-methoxy-2-propionamidotetralin | 8-methoxy-2-propionamidotetralin: enhances sperm hyperactivation via the MT1 receptor | tetralins | |
k 185 | |||
ucm 454 | |||
5-hydroxyethoxy-n-acetyltryptamine | 5-hydroxyethoxy-N-acetyltryptamine: structure in first source |